Gianluca Spitaleri

3.3k total citations
83 papers, 2.1k citations indexed

About

Gianluca Spitaleri is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Gianluca Spitaleri has authored 83 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 48 papers in Pulmonary and Respiratory Medicine and 21 papers in Molecular Biology. Recurrent topics in Gianluca Spitaleri's work include Lung Cancer Treatments and Mutations (38 papers), Lung Cancer Research Studies (15 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Gianluca Spitaleri is often cited by papers focused on Lung Cancer Treatments and Mutations (38 papers), Lung Cancer Research Studies (15 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Gianluca Spitaleri collaborates with scholars based in Italy, France and United States. Gianluca Spitaleri's co-authors include Filippo de Marinis, Filippo de Braud, Tommaso De Pas, Antonio Passaro, Chiara Catania, Massimo Barberis, Cristina Noberasco, Ester Del Signore, Francesca Toffalorio and Lorenzo Spaggiari and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and Clinical Cancer Research.

In The Last Decade

Gianluca Spitaleri

81 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gianluca Spitaleri Italy 26 1.1k 985 504 403 327 83 2.1k
Jacques Médioni France 29 1.2k 1.1× 1.4k 1.5× 1.0k 2.0× 293 0.7× 584 1.8× 125 3.3k
Yoichi Naito Japan 27 1.7k 1.5× 1.1k 1.1× 623 1.2× 348 0.9× 428 1.3× 150 2.7k
Carlo Tondini Italy 28 1.2k 1.1× 476 0.5× 363 0.7× 174 0.4× 567 1.7× 104 2.3k
Naoki Niikura Japan 26 1.7k 1.5× 902 0.9× 330 0.7× 511 1.3× 918 2.8× 147 2.5k
Richard L. White United States 24 1.3k 1.1× 393 0.4× 461 0.9× 283 0.7× 409 1.3× 81 2.1k
Carla I. Falkson United States 26 1.8k 1.6× 528 0.5× 811 1.6× 316 0.8× 797 2.4× 95 2.8k
J. Doyen France 22 716 0.6× 661 0.7× 520 1.0× 211 0.5× 617 1.9× 101 1.9k
Francisco Robert United States 28 1.8k 1.6× 1.4k 1.4× 1.1k 2.2× 290 0.7× 312 1.0× 107 3.2k
Hans‐Joachim Lück Germany 28 1.9k 1.6× 572 0.6× 395 0.8× 298 0.7× 721 2.2× 67 2.9k
Yasushi Goto Japan 30 2.5k 2.2× 2.2k 2.3× 854 1.7× 216 0.5× 602 1.8× 246 3.8k

Countries citing papers authored by Gianluca Spitaleri

Since Specialization
Citations

This map shows the geographic impact of Gianluca Spitaleri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gianluca Spitaleri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gianluca Spitaleri more than expected).

Fields of papers citing papers by Gianluca Spitaleri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gianluca Spitaleri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gianluca Spitaleri. The network helps show where Gianluca Spitaleri may publish in the future.

Co-authorship network of co-authors of Gianluca Spitaleri

This figure shows the co-authorship network connecting the top 25 collaborators of Gianluca Spitaleri. A scholar is included among the top collaborators of Gianluca Spitaleri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gianluca Spitaleri. Gianluca Spitaleri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Angelopoulos, Panagiotis, Antonio Passaro, Ilaria Attili, et al.. (2025). Management of MET-Driven Resistance to Osimertinib in EGFR-Mutant Non-Small Cell Lung Cancer. Genes. 16(7). 772–772. 1 indexed citations
2.
Attili, Ilaria, Luca Bertolaccini, Carla Corvaja, et al.. (2025). Actionable Gene Alterations in Resected Non-Small Cell Lung Cancer: Primary Results From the AGA-R Study. Clinical Lung Cancer. 27(2). 259–268.e8.
3.
Aliaga, Pamela Trillo, Gianluca Spitaleri, Ilaria Attili, et al.. (2025). HER2 in Non-Small Cell Lung Cancer (NSCLC): Evolution of the Therapeutic Landscape and Emerging Drugs—A Long Way to the Top. Molecules. 30(12). 2645–2645. 2 indexed citations
4.
Attili, Ilaria, Carla Corvaja, Pamela Trillo Aliaga, et al.. (2024). Management of Non-Metastatic Non-Small Cell Lung Cancer (NSCLC) with Driver Gene Alterations: An Evolving Scenario. Current Oncology. 31(9). 5121–5139. 7 indexed citations
5.
Attili, Ilaria, Davide Vacirca, Alessandra Rappa, et al.. (2024). Co-Occurring Driver Genomic Alterations in Advanced Non-Small-Cell Lung Cancer (NSCLC): A Retrospective Analysis. Journal of Clinical Medicine. 13(15). 4476–4476. 5 indexed citations
6.
Attili, Ilaria, Carla Corvaja, Gianluca Spitaleri, et al.. (2024). Post-Progression Analysis of EGFR-Mutant NSCLC Following Osimertinib Therapy in Real-World Settings. Cancers. 16(14). 2589–2589. 7 indexed citations
7.
8.
Spitaleri, Gianluca, Pamela Trillo Aliaga, Ilaria Attili, et al.. (2024). Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: “Shadows and Fogs”. Cancers. 16(16). 2877–2877. 2 indexed citations
9.
Aliaga, Pamela Trillo, Ester Del Signore, Gianluca Spitaleri, et al.. (2024). The Evolving Scenario of ES-SCLC Management: From Biology to New Cancer Therapeutics. Genes. 15(6). 701–701. 1 indexed citations
10.
Spitaleri, Gianluca, Pamela Trillo Aliaga, Ilaria Attili, et al.. (2023). MET in Non-Small-Cell Lung Cancer (NSCLC): Cross ‘a Long and Winding Road’ Looking for a Target. Cancers. 15(19). 4779–4779. 12 indexed citations
11.
Attili, Ilaria, Carla Corvaja, Gianluca Spitaleri, et al.. (2023). New Generations of Tyrosine Kinase Inhibitors in Treating NSCLC with Oncogene Addiction: Strengths and Limitations. Cancers. 15(20). 5079–5079. 27 indexed citations
12.
Attili, Ilaria, Carmine Valenza, Gabriele Antonarelli, et al.. (2022). Comparison of real-world data (RWD) analysis on efficacy and post-progression outcomes with pembrolizumab plus chemo vs chemo alone in metastatic non-squamous non-small cell lung cancer with PD-L1 < 50%. Frontiers in Oncology. 12. 980765–980765. 6 indexed citations
13.
Catania, Chiara, Antonio Passaro, Elena Guerini‐Rocco, et al.. (2016). Dramatic Antitumor Activity of Nivolumab in Advanced HER2-Positive Lung Cancer. Clinical Lung Cancer. 17(5). e179–e183. 4 indexed citations
14.
Gainor, Justin F., Daniel Shao-Weng Tan, Benjamin Solomon, et al.. (2015). Progression-Free and Overall Survival in ALK-Positive NSCLC Patients Treated with Sequential Crizotinib and Ceritinib. Clinical Cancer Research. 21(12). 2745–2752. 135 indexed citations
15.
Catania, Chiara, Edoardo Botteri, Massimo Barberis, et al.. (2015). Molecular Features and Clinical Outcome of Lung Malignancies in Very Young People. Future Oncology. 11(8). 1211–1221. 11 indexed citations
16.
Spitaleri, Gianluca, Antonio Toesca, Edoardo Botteri, et al.. (2013). Breast phyllodes tumor: A review of literature and a single center retrospective series analysis. Critical Reviews in Oncology/Hematology. 88(2). 427–436. 141 indexed citations
17.
Eigentler, Thomas, Benjamin Weide, Filippo de Braud, et al.. (2011). A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma. Clinical Cancer Research. 17(24). 7732–7742. 125 indexed citations
18.
Pas, Tommaso De, Francesca Toffalorio, Michela Manzotti, et al.. (2011). Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor Receptor Mutations. Journal of Thoracic Oncology. 6(11). 1895–1901. 106 indexed citations
19.
Curigliano, Giuseppe, Gianluca Spitaleri, Elisabetta Pietri, et al.. (2005). Breast cancer vaccines: a clinical reality or fairy tale?. Annals of Oncology. 17(5). 750–762. 78 indexed citations
20.
Adamo, Vincenzo, Giuseppa Ferraro, Stefano Pergolizzi, et al.. (2004). Paclitaxel and cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma. Oral Oncology. 40(5). 525–531. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacques Médioni Breakdown of academic impact, for papers by Yoichi Naito Breakdown of academic impact, for papers by Carlo Tondini Breakdown of academic impact, for papers by Naoki Niikura Breakdown of academic impact, for papers by Richard L. White Breakdown of academic impact, for papers by Carla I. Falkson Breakdown of academic impact, for papers by J. Doyen Breakdown of academic impact, for papers by Francisco Robert Breakdown of academic impact, for papers by Hans‐Joachim Lück Breakdown of academic impact, for papers by Yasushi Goto
Rankless by CCL
2026